| Expense Ratio | 0.21% |
| Avg. PE ratio | 32.16 |
| Avg. PB ratio | 4.69 |
| AUM | ₹990.57 Cr. |
| Companies | 1D Returns |
| 0.25 | |
| 0.25 | |
| 0.04 | |
| 1.87 | |
| 0.47 |
Sector
Market Cap
Insights help you understand the recent movement of the ETF's critical parameters, giving you an overall view of the ETF.
Price Rise
![]()
In the last 3 years, Nippon India NIFTY Pharma ETF Growth Plan has moved up by 71.18%
Against Peers
![]()
In the last 1 year, Motilal Oswal S&P BSE Healthcare ETF has given 4.33% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 6.30%.
Against Peers
![]()
In the last 3 year, Motilal Oswal S&P BSE Healthcare ETF has given 97.57% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 26.39%.
Market Cap Breakup
![]()
Market Cap breakup for Nippon India NIFTY Pharma ETF Growth Plan is 56.25% in LARGE CAP, 33.08% in MID CAP and 10.66% in SMALL CAP with top sector being Pharmaceuticals with 100.00%
| Exchange | NSE |
| E-voting on shares | Click here to vote |
Nippon India NIFTY Pharma ETF Growth Plan share price today stands at ₹22.84, Open: ₹22.83, Previous Close: ₹22.87, High: ₹23.02, Low: ₹22.81, 52 Week High: ₹24.65, 52 Week Low: ₹19.47.
You can invest via your demat account in the Nippon India NIFTY Pharma ETF Growth Plan. You can invest either through SIP mode or lumpsum mode.
Yes. Nippon India NIFTY Pharma ETF Growth Plan is available for SIP on INDmoney platform for daily, weekly or monthly SIP.
Nippon India NIFTY Pharma ETF Growth Plan's drawbacks are not related to specifically Nippon India NIFTY Pharma ETF Growth Plan. In Indian context, some of the ETFs have a drawbacks of higher tracking, lower trading volumes, etc.
Yes. Nippon India NIFTY Pharma ETF Growth Plan can used as collateral for a loan under Loan Against Securities.